Cunningham, Richard Anthony 4
4 · Anebulo Pharmaceuticals, Inc. · Filed Oct 11, 2023
Insider Transaction Report
Form 4
Cunningham, Richard Anthony
DirectorChief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2023-10-06+600,000→ 600,000 totalExercise: $3.03Exp: 2033-10-05→ Common Stock (600,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest and become exercisable as follows: ratably in 16 quarterly installments (37,500 per installment) on the first day of each calendar quarter commencing with January 1, 2024, such that option will be full vested on October 1, 2027.